Call Options Transactions Made in Q3 2022 in Satsuma Pharmaceuticals, Inc. (STSA)
This table provides information about the institutional ownership of Satsuma Pharmaceuticals, Inc. (STSA) during Q3 2022. The information is specifically focused on institutions that hold call options of Satsuma Pharmaceuticals, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2022
Q3 2022
|
Ikarian Capital, LLC
Dallas, TX |
BUY
|
CALL |
400KNew |
$1.68M - $3.18M
|
400K
$0
|
|
Nov 14, 2022
Q3 2022
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
CALL |
200KNew |
$838K - $1.59M
|
200K
$0
|
|
Nov 14, 2022
Q3 2022
|
Boothbay Fund Management, LLC
New York, NY |
BUY
|
CALL |
71.5KNew |
$300K - $568K
|
71.5K
$0
|
|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
26.7KNew |
$112K - $212K
|
26.7K
$0
|
|
Nov 14, 2022
Q3 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
24.2KNew |
$101K - $192K
|
24.2K
$0
|